Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
Micro Penny Stocks, Penny Stocks $0.10 & Under
»
XKEM
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is not enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by madmax526: [QB] Great post from Googleaire!! From: Googleaire - view profile Date: Tues, Oct 10 2006 12:11 pm Email: "Googleaire" <4alli...*optonline.net> Not yet rated Rating: show options Reply | Reply to Author | Forward | Print | Individual Message | Report Abuse | Find messages by this author Max: do you think that XKEM was heavily shorted on the run up to .11?? By 'heavily shorted' if you mean in the neighborhood of 2Billion shares then 'yes'. The question now is have the 'shorts' FULLY covered? No Anticipate one more 'short cover' rally before the 5B A/S meeting then the .02+- to .03+- trading range continues until the next phase of the 'Trading Plan' continues. First the 5B A/S of new stock [actually 3B] will used as collateral to secure the loans [so nothing big happens until then]. 2nd The public market for stock provides the exit strategy and liquidity to the insiders and the Market-Makers that initiated the trading plan. There are over 500 member firms that act as NASDAQ Market-Makers and just as 'most' companies have a business plan they have a 'Trading Plan' when the A/S is being increased. One of the most important benefits of a 'public offering' is the fact that the company's stock eventually becomes liquid, offering rewards and financial freedom for the founders, employees AND FAST ACTING TRADERS WHO RECOGNIZE THE OPPORTUNITY. With the accurate use of press releases, interviews or news stories and released in a 'timely' manner they are designed to encourage and increase investor/Main St Awareness, create shareholder value [lol, that ones funny] and demand for the stock. A well orchestrated ad campaign coupled with media initiatives has the potential to increase volume making dilution the final step. Let's take a look at the XKEM YTD Media Campaign in progress; * October 4, 2006 o Xechem Receives $473,181 SBIR Grant to Conduct Toxicity Studies of 5-HMF Compound * September 12, 2006 o Xechem Chairman, Dr. Ramesh Pandey, to Present NICOSAN at 34th Annual SCDAA Conference * August 29, 2006 o Xechem Chairman Responds to Shareholder Questions Regarding NICOSAN * July 26, 2006 o Demand for New Sickle Cell Drug NICOSAN Far Exceeds Supply * July 11, 2006 o Nigerian President Olusegun Obasanjo Launches Xechem's Sickle Cell Drug, NICOSAN * July 5, 2006 o Xechem Receives Approval For Sale Of NICOSAN From Nigerian Regulatory Authorities - NAFDAC * June 6, 2006 o Xechem Receives Orphan Drug Designation From The FDA For Its Anti-Sickling Drug 5-HMF * June 1, 2006 o Xechem Pharmaceuticals Nigeria - Receives $1.2 million dollar loan from NEXIM Bank * April 17, 2006 o Xechem files Orphan Drug Application with the FDA for the anti-sickling compound. * January 25, 2006 o Xechem closes on $4.2 million lawsuit settlement with Bristol-Meyers Three years ago; [Sept. 2, 2003--Xechem International, Inc. (OTC BB: XKEM) announced that it received Orphan Drug designation for NIPRISAN (HEMOXIN(TM)from the U.S. Food and Drug Administration] Keep that in mind because the BIG XKEM pps rally will revolve around 'that story' or something JUST AS unique and I anticipate that's coming soon; Q-4 or early in 2007. Employees and officers have two ways to add to their wealth: by receiving a salary and selling stock. Ever since the Form Type: 8-K Filing Date: 9/25/2006 XKEM is getting crushed even with the $500K Grant PR. Hmmmmmm, SURE THAT WILL FRUSTRATE MAIN ST. Let's look at the major players /MM's for XKEM [excluding the Hedge Funds]; NITE [KNIGHT EQUITY MARKETS, L.P] YTD trading in XKEM is 3,481,789,955 shares while the #2 MM is UBSS [UBS Securities LLC] 2,681,033,210 shares traded YTD but UBSS has backed off in XKEM trading activity substantially after July. Keep an eye on UBSS after the 5B A/S is approved BECAUSE they and NITE will be working to liquidate any new shares that XKEM has scheduled for dilution. NOTE; ETRD [E*TRADE CAPITAL MARKETS LL] is your #3 MM serving the momentum traders [912,049,803 XKEM shares traded YTD]. Next the Main St speculator needs to establish what the 'trading plan' is. With XKEM that's pretty easy. Look at the XKEM One-Year 'monthly chart' at Big Charts.com and you'll see that manipulation volume is done quarterly. As mentioned previously the 4th Quarter volume on the OTCBB is the most active because the Big Money Managers aka Hedge Funds are back in the game AND THEY KNOW WHATS ABOUT TO HAPPEN. It's no coincidence that the 5B A/S is coming in Q-4 folks. For the near-term XKEM will be trading on low volume as the Shorts continue to capitalize while they continue to SQUEEZE Longs who paid over 5cents. Main St Longs are 85% fed up and closing out their positions and the fact is; this is when they need to be building their positions but sheep will be sheep. Remember back in Q-3 XKEM traded $31,000,000.00 IN ONE DAY. Wait until the Q4 Hedge Funds get involved XKEM you'll see $100,000,000.00 and that's when you'll know its time to SELL. Again the build-up in Money Flow [and volume] up to that day will be based on NEWS i.e. FDA news weather it's good or bad or something almost as dramatic as the FDA. The time frame for the new rally will be weeks/months [not a one-day pump 'n' dump plan] because there are additional variables with the XKEM story. Did the Shorts make money? YOU BET THEY DID!!! Can you make money? YOU BET YOU WILL! Just is PATIENT!!! [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2